Skip Navigation LinksInfantBotulism


The mission of the IBTPP is to provide and improve the treatment of infant botulism and to prevent infant botulism and related diseases. 

BabyBIG® Packaging
Gram Stain Clostridiumbotulinum
BabyBIG® Information and OrderingLaboratory and Diagnostic Info

Please click on photos above for more information about how to obtain BabyBIG®, consultation for suspected infant botulism, and laboratory testing in California.

Also visit our infant botulism main page for in-depth information.

What is infant botulism? Infant botulism is an orphan ("rare") disease that affects infants ​primarily under 1 year of age. First recognized in 1976, infant botulism occurs globally and is the most common form of human botulism in the United States.

BabyBIG®, Botulism Immune Globulin Intravenous (Human) (BIG-IV) is an orphan drug that consists of human-derived anti-botulism toxin antibodies that is approved by the U.S. Food and Drug Administration for the treatment of infant botulism type A and type B. 

Contact us by phone, fax, or email:

Phone: Physicians with a suspected case of infant botulism may reach our program at (510) 231-7600 (24/7/365). However, if you are a parent with concerns or questions about suspected infant botulism, please contact your pediatrician.

Email: If you have non-urgent questions or comments, please email the program at: ​​

Fax: (510) 231-7609

For more in-depth information, please visit our infant botulism main page.

Page Last Updated :